Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?
Hendriks LEL, Brouns -JWM, Amini M, Uyterlinde W, Wijsman R, Bussink J, Biesma B, Oei SB, Stigt JA, Bootsma GP, Belderbos JSA, De Ruysscher DKM, Van den Heuvel MM, Dingemans AC. Hendriks LEL, et al. Among authors: bussink j. Lung Cancer. 2016 Nov;101:68-75. doi: 10.1016/j.lungcan.2016.09.008. Epub 2016 Sep 9. Lung Cancer. 2016. PMID: 27794410 Free article.
Role of FDG-PET in the diagnosis and management of lung cancer.
Oyen WJ, Bussink J, Verhagen AF, Corstens FH, Bootsma GP. Oyen WJ, et al. Among authors: bussink j. Expert Rev Anticancer Ther. 2004 Aug;4(4):561-7. doi: 10.1586/14737140.4.4.561. Expert Rev Anticancer Ther. 2004. PMID: 15270660 Review.
Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer.
Soetekouw PM, Timmer-Bonte JN, van der Drift MA, van Leeuwen F, Wagenaar M, van Die L, Bussink J, Tjan-Heijnen VC. Soetekouw PM, et al. Among authors: bussink j. Int J Clin Oncol. 2013 Dec;18(6):988-96. doi: 10.1007/s10147-012-0476-7. Epub 2012 Sep 27. Int J Clin Oncol. 2013. PMID: 23011101 Clinical Trial.
High NOTCH activity induces radiation resistance in non small cell lung cancer.
Theys J, Yahyanejad S, Habets R, Span P, Dubois L, Paesmans K, Kattenbeld B, Cleutjens J, Groot AJ, Schuurbiers OCJ, Lambin P, Bussink J, Vooijs M. Theys J, et al. Among authors: bussink j. Radiother Oncol. 2013 Sep;108(3):440-445. doi: 10.1016/j.radonc.2013.06.020. Epub 2013 Jul 25. Radiother Oncol. 2013. PMID: 23891097 Free PMC article.
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C, Dunant A, Senan S, Wolfson A, Quoix E, Faivre-Finn C, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche A; Prophylactic Cranial Irradiation (PCI) Collaborative Group. Le Péchoux C, et al. Lancet Oncol. 2009 May;10(5):467-74. doi: 10.1016/S1470-2045(09)70101-9. Epub 2009 Apr 20. Lancet Oncol. 2009. PMID: 19386548 Clinical Trial.
HPV, hypoxia and radiation response in head and neck cancer.
Göttgens EL, Ostheimer C, Span PN, Bussink J, Hammond EM. Göttgens EL, et al. Among authors: bussink j. Br J Radiol. 2019 Jan;92(1093):20180047. doi: 10.1259/bjr.20180047. Epub 2018 Mar 14. Br J Radiol. 2019. PMID: 29493265 Free PMC article. Review.
258 results